Identification

Symbol
IPH
ISIN code
FR0010331421
Trading location
Paris
ICB
Biotechnology
Website address
http://www.innate-pharma.com/
Issuer website
http://www.innate-pharma.com/

Operation

IPO date
Tue 31/10/2006
IPO type

Global Placement and Open Price Offer

IPO price
4.50 euros
IPO type
Initial Public offering
Catégorie
IPO
Operation procedure

Open Price Offer procedure Subscription open for mainly Retail investors. Number of shares: a maximum of 554,217 shares after exercise of extension option and before exercise of Green Shoe. Extension option: According to the importance of demand, Innate Pharma and in accordance with the bookrunners-leadmanagers, Bryan, Garnier and Co Limited and SOCIETE GENERALE Corporate and Investment Banking could decide to increase the number of shares offered to the public up to 722,891 additional new shares (i.e a maximum of 15% of the number of shares initially offered to the public).

Operation description

Admission on Eurolist by Euronext :

  • 17,264,080 existing shares representing the outstanding share capital of Innate Pharma,
  • a maximum of 4,819,277 new shares by way of public offering,
  • a maximum of 722,891 new shares from the exercise of the extension option,
  • a maximum of 831,325 new shares from the exercise of the Green Shoe,
  • a maximum of 1,204,819 new shares from a capital increase reserved to the shareholder Novo Nordisk A/S.

A maximum of 4,819,277 shares (before extension option and Green shoe) will be made available and distributed to the public within the framework of a Global Placement and an Open price Offer.

The shares will be admitted temporarily on Eurolist by Euronext under the title "Innate Pharma Promesses".

Operation calendar

- Period of the OPO : From October 19th, 2006 to October 30th, 2006 (17:00) - First quotation: October 31st, 2006 - Beginning of trading: November 1st, 2006 - From 1st to 3rd November 2006 inclusive: trading of new and existing shares on a single quotation line "Innate Pharma Promesses" under the ISIN code FR0010331421 and mnemonic IPH. - From 4th November 2006: the shares will be quoted under the title "Innate Pharma", ISIN code FR0010331421 (unchanged) and mnemonic IPH (unchanged).

Price range
4.15 euros - 4.80 euros
Broker to issue

SOCIETE GENERALE Corporate and Investment Banking
BRYAN, GARNIER and Co Limited